Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Jaguar Health, Inc. JAGX

Set alert

Price alert · JAGX

All alert types
0.88 USD -0.74 -45.43%

At close

0.65 -0.23 -26.14%

Pre-market · Nov 3, 7:30 AM ET

Bid
0.87 × 1
Ask
0.89 × 1
0.81 Day range 0.9649
0.81 52-week range 1,102.50
YTD
-99.82%
1 year
-99.91%
Open
0.9601
Prev close
1.62
Mkt cap
2.05M
Vol
2.20M
Avg vol
2.19M
EPS
-4,012.65
P/E
0.00
Div yield
0.00%
More statistics
Low
0.81
High
0.9649
Forward P/E
-0.37
Beta
0.88
Short ratio
1.12
Inst. own
1.96%
Dividend
0.00
Ex-div date
50-d avg
1.04
200-d avg
3.85
1y target
6.00

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Jun 1, 2018Split: 1 for 5
  • Jun 7, 2019Split: 1 for 70
  • Mar 2, 2026Split: 1.1 for 1
Signals (8)
NameDateAgo
SMA: BearishJul 1, 20215 years ago
SMA: BullishDec 1, 20205 years ago
SMA: BearishAug 1, 20206 years ago
SMA: BullishJul 1, 20206 years ago
RSI: OversoldMay 1, 20188 years ago
RSI: OversoldSep 1, 20179 years ago
SMA: BearishMar 1, 20179 years ago
SMA: BullishFeb 1, 20179 years ago

Financial health

Altman Z-Score

-20.02 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.0×
FY 2016: -0.2×FY 2017: -0.1×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.3×FY 2021: -0.3×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.2×FY 2025: -0.0×
FY 2016 5y median -0.1× FY 2025
P/S 0.2×
FY 2016: 18.5×FY 2017: 0.5×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 1.1×FY 2021: 3.6×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.6×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
P/B -0.1×
FY 2016: -1.1×FY 2017: 0.1×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.6×FY 2021: 1.3×FY 2022: -4.3×FY 2023: 0.2×FY 2024: 1.0×FY 2025: -0.1×
FY 2016 5y median 0.2× FY 2025
P/FCF 0.4×
FY 2016: -0.2×FY 2017: -0.2×FY 2018: -0.0×FY 2019: -0.1×FY 2020: -0.7×FY 2021: -0.4×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.3×FY 2025: 0.4×
FY 2016 5y median -0.1× FY 2025
EV/EBITDA -0.9×
FY 2016: -0.4×FY 2017: -1.6×FY 2018: -0.5×FY 2019: -0.2×FY 2020: -0.6×FY 2021: -0.7×FY 2022: -1.0×FY 2023: -1.0×FY 2024: -1.0×FY 2025: -0.9×
FY 2016 5y median -1.0× FY 2025
EV/Sales 3.9×
FY 2016: 39.2×FY 2017: 4.1×FY 2018: 3.3×FY 2019: 0.9×FY 2020: 2.0×FY 2021: 6.4×FY 2022: 2.7×FY 2023: 3.3×FY 2024: 3.1×FY 2025: 3.9×
FY 2016 5y median 3.3× FY 2025
FCF Yield 265.8%
FY 2016: -555.7%FY 2017: -485.4%FY 2018: -2030.5%FY 2019: -1542.9%FY 2020: -145.6%FY 2021: -225.7%FY 2022: -1220.6%FY 2023: -2882.4%FY 2024: -398.2%FY 2025: 265.8%
FY 2016 5y median -398.2% FY 2025

Profitability

Gross Margin 67.2%
FY 2016: 63.3%FY 2017: 79.8%FY 2018: 37.4%FY 2019: 33.9%FY 2020: 65.1%FY 2021: 46.2%FY 2022: 83.1%FY 2023: 79.1%FY 2024: 83.3%FY 2025: 67.2%
FY 2016 5y median 79.1% FY 2025
Operating Margin -391.9%
FY 2016: -9599.8%FY 2017: -785.3%FY 2018: -698.0%FY 2019: -501.3%FY 2020: -283.9%FY 2021: -939.1%FY 2022: -287.8%FY 2023: -351.3%FY 2024: -263.8%FY 2025: -391.9%
FY 2016 5y median -351.3% FY 2025
Net Margin -464.2%
FY 2016: -10410.9%FY 2017: -503.7%FY 2018: -727.9%FY 2019: -667.3%FY 2020: -360.2%FY 2021: -1213.3%FY 2022: -396.9%FY 2023: -423.1%FY 2024: -329.3%FY 2025: -464.2%
FY 2016 5y median -423.1% FY 2025
ROE 309.1%
FY 2016: 600.4%FY 2017: -127.3%FY 2018: -597.2%FY 2019: -361.1%FY 2020: -196.5%FY 2021: -453.0%FY 2022: 7222.8%FY 2023: -832.5%FY 2024: -528.4%FY 2025: 309.1%
FY 2016 5y median -453.0% FY 2025
ROIC -178.3%
FY 2016: -943.5%FY 2017: -63.6%FY 2018: -101.2%FY 2019: -102.9%FY 2020: -79.8%FY 2021: -98.8%FY 2022: -102.8%FY 2023: -81.7%FY 2024: -66.9%FY 2025: -178.3%
FY 2016 5y median -98.8% FY 2025
ROA -139.4%
FY 2016: -413.5%FY 2017: -50.4%FY 2018: -78.3%FY 2019: -105.8%FY 2020: -78.9%FY 2021: -98.7%FY 2022: -100.0%FY 2023: -81.4%FY 2024: -72.0%FY 2025: -139.4%
FY 2016 5y median -98.7% FY 2025

Growth (YoY)

Revenue -1.5%
FY 2016: -45.2%FY 2017: 2981.6%FY 2018: 1.3%FY 2019: 30.8%FY 2020: 62.5%FY 2021: -53.8%FY 2022: 175.8%FY 2023: -18.4%FY 2024: 19.8%FY 2025: -1.5%
FY 2016 FY 2025
Operating Income -46.3%
FY 2016: -9.2%FY 2017: -152.1%FY 2018: 10.0%FY 2019: 6.1%FY 2020: 7.9%FY 2021: -52.8%FY 2022: 15.5%FY 2023: 0.4%FY 2024: 10.1%FY 2025: -46.3%
FY 2016 FY 2025
EPS (diluted) 82.4%
FY 2016: 50.0%FY 2017: 62.2%FY 2018: 71.4%FY 2019: 94.1%FY 2020: 88.9%FY 2021: 60.8%FY 2022: 59.0%FY 2023: 95.1%FY 2024: 95.1%FY 2025: 82.4%
FY 2016 FY 2025
Free Cash Flow 119.5%
FY 2016: -1.2%FY 2017: 32.3%FY 2018: -131.4%FY 2019: 10.0%FY 2020: 25.3%FY 2021: -128.8%FY 2022: 0.6%FY 2023: 4.4%FY 2024: 10.9%FY 2025: 119.5%
FY 2016 FY 2025

Financial Health

Current Ratio 0.5×
FY 2016: 0.6×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 0.6×FY 2020: 1.3×FY 2021: 1.8×FY 2022: 0.7×FY 2023: 2.0×FY 2024: 1.6×FY 2025: 0.5×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 0.3×
FY 2016: 0.5×FY 2017: 0.1×FY 2018: 0.2×FY 2019: 0.5×FY 2020: 1.1×FY 2021: 1.5×FY 2022: 0.5×FY 2023: 1.3×FY 2024: 1.1×FY 2025: 0.3×
FY 2016 5y median 1.1× FY 2025
Debt / Equity -2.5×
FY 2016: -1.6×FY 2017: 1.0×FY 2018: 3.0×FY 2019: 0.7×FY 2020: 0.9×FY 2021: 2.5×FY 2022: -53.0×FY 2023: 7.5×FY 2024: 5.0×FY 2025: -2.5×
FY 2016 5y median 2.5× FY 2025
Net Debt / EBITDA -0.8×
FY 2016: -0.2×FY 2017: -1.4×FY 2018: -0.5×FY 2019: -0.1×FY 2020: -0.3×FY 2021: -0.3×FY 2022: -0.9×FY 2023: -1.0×FY 2024: -0.8×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
Interest Coverage 673×
FY 2016: -13.8×FY 2017: -28.3×FY 2018: -11.7×FY 2019: -5.1×FY 2020: -9.5×FY 2021: -4.8×FY 2022: -2.7×FY 2023: -5.4×FY 2024: -133×FY 2025: 673×
FY 2016 5y median -4.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31